Genetically engineered virulent phage banks in the detection and control of emergent pathogenic bacteria.
Natural outbreaks of multidrug-resistant microorganisms can cause widespread devastation, and several can be used or engineered as agents of bioterrorism. From a biosecurity standpoint, the capacity to detect and then efficiently control, within hours, the spread and the potential pathological effects of an emergent outbreak, for which there may be no effective antibiotics or vaccines, become key challenges that must be met. We turned to phage engineering as a potentially highly flexible and effective means to both detect and eradicate threats originating from emergent (uncharacterized) bacterial strains. To this end, we developed technologies allowing us to (1) concurrently modify multiple regions within the coding sequence of a gene while conserving intact the remainder of the gene, (2) reversibly interrupt the lytic cycle of an obligate virulent phage (T4) within its host, (3) carry out efficient insertion, by homologous recombination, of any number of engineered genes into the deactivated genomes of a T4 wild-type phage population, and (4) reactivate the lytic cycle, leading to the production of engineered infective virulent recombinant progeny. This allows the production of very large, genetically engineered lytic phage banks containing, in an E. coli host, a very wide spectrum of variants for any chosen phage-associated function, including phage host-range. Screening of such a bank should allow the rapid isolation of recombinant T4 particles capable of detecting (ie, diagnosing), infecting, and destroying hosts belonging to gram-negative bacterial species far removed from the original E. coli host.
Pouillot
Flavie
F
Pherecydes Pharma, Romainville, France. flavie.pouillot@pherecydes-pharma.com
Blois
Hélène
H
Iris
François
F
D001419:Bacteria / Q000472:pathogenicity*; D001435:Bacteriophages / Q000235:genetics*; D018070:Biological Specimen Banks; D021821:Communicable Diseases, Emerging / Q000453:epidemiology / Q000382:microbiology; D004196:Disease Outbreaks / Q000517:prevention & control; D005818:Genetic Engineering / Q000379:methods*; D006801:Humans; D030781:Organisms, Genetically Modified; D014774:Virulence